We also studied the efficacy of the combination of Y90 RMS and sorafenib in our retrospective analysis. The median OS from the start of treatment with sorafenib was 19.52 months (95% CI, 9.23–33.68 months), and OS rates were 62.3% at 1 year and 31.7% at 2 years, according to Kaplan–Meier analysis. These findings are impressive when compared with those of the SHARP trial (median OS, 10.7 months; 1-year OS rate, 44%)1 and the Sorafenib Asia–Pacific trial (median OS, 6.5 months).3 PFS in our study was 6.63 months, which is 1 month longer than that reported in the SHARP trial. We also observed a partial response in 19% of patients and stable disease in 81% of patients. This is superior to data reported in the SHARP trial, in which partial response was recorded in 2% of patients and stable disease in 71% of patients.1
Great find Cafa, thanks for sharing. Small retrospective study, but can't help but think this bodes well for SARAH. A dual SIRT-Sorafenib arm would have been nice to include.
- Forums
- ASX - By Stock
- SRX
- Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellula
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellula, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.8¢ | 17.5¢ | $68.91K | 393.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3966005 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2611882 | 37 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3966005 | 0.175 |
6 | 1607688 | 0.170 |
1 | 18186 | 0.165 |
1 | 2577 | 0.097 |
1 | 4000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 1957882 | 33 |
0.185 | 100499 | 6 |
0.190 | 185422 | 8 |
0.195 | 520478 | 3 |
0.200 | 187653 | 8 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |